EVP, State Advocacy @PhRMA. Working to make medicine more accessible & affordable for patients. Dad, husband & fan of @Arsenal, @NYRangers, @umterps & travel
Washington, DC
Joined June 2009
- Tweets1.7K
- Following488
- Followers625
- Likes1K
Scott LaGanga retweeted
The FDA approved a therapy from Revolution Medicines that slows a cancer that kills 7 of out 8 patients within five years. on.wsj.com/4gfZhbq
Scott LaGanga retweeted
Bukayo Saka recreated the pic from 2020 when you posted: “You deserve more, Arsenal fans”.
…and he delivered. ❤️🤍🏆
Scott LaGanga retweeted
All of the recent attention on pancreatic cancer diagnosis and treatment shows clear momentum that adds up to something important: real hope for patients facing this terrible disease. #KRAS #AI #pancan
A Mayo Clinic-developed artificial intelligence (AI) model can help specialists detect pancreatic cancer on routine abdominal CT scans up to three years before clinical diagnosis. It identifies subtle signs of disease before tumors are visible, when curative treatment may still be possible. The findings, published in Gut, mark a milestone in Mayo Clinic's multiyear research effort to enable earlier detection of one of the deadliest cancers.
Learn more: mayocl.in/4eippBP
Scott LaGanga retweeted
Minnesota report shows large hospitals continue to dominate the 340B drug discount program.. statnews.com/pharmalot/2026/… #pharma #hospitals #340B #Minnesota #medicines
Scott LaGanga retweeted
Direct purchase programs let patients buy certain medicines directly from manufacturers — reducing hidden markups and middlemen barriers. America’s Medicines and our team highlight these tools, and what must be done to drive down surprise markups and fees.
phrma.org/blog/no-hassle-hid…
Scott LaGanga retweeted
Moderated by @annikakimc and joined by National MPS Society CEO @terrilklein and NORD CEO Pamela Gavin, Takeda CEO-elect Julie Kim talked about the surge in innovation that has led to increased clinical trials and therapies for patients with rare diseases.
Scott LaGanga retweeted
America’s leadership in medicine development matters.
America has delivered lifesaving breakthroughs and fueled economic opportunity nationwide.
For the first time in decades, America’s spot as a global leader is on the line.
Learn how smart policies can keep us in the lead:
Scott LaGanga retweeted
Yesterday’s hearing highlighted a stark reality in American health care.
The five largest health insurers aren’t just insurance companies — they are massive health care empires, controlling insurance plans, PBMs, medical providers and pharmacies under one roof.
Today, just three health insurers control half of the market, and three PBMs control 80 percent of drug benefits — leaving patients with fewer choices and less competition.
Scott LaGanga retweeted
"It's Clinical"
No it isn't. There are no published data for this.
Full page ad in @nytimes
Scott LaGanga retweeted
#News Today we announced our plans to invest $4.5 billion in a new manufacturing facility in Virginia. This includes a proposed $500m increase to support enhanced manufacturing capability, driving life sciences innovation and economic growth: spr.ly/6012As4Qw
Scott LaGanga retweeted
The White House is proposing a reform of the obscure 340B drug program, which enriches large hospitals at the expense of patients. Cue the protests from the hospital lobby.
on.wsj.com/3InFcSq
Scott LaGanga retweeted
Another major win for Virginia! @AstraZeneca has chosen the Commonwealth for its largest single manufacturing investment in the world, creating hundreds of high-skilled science and technology jobs and strengthening America’s pharmaceutical supply chain.
Thank you to AstraZeneca for choosing Virginia as the cornerstone for this transformational investment in the United States. This partnership positions the Commonwealth at the cutting edge of pharmaceutical innovation worldwide.
Scott LaGanga retweeted
mRNA tech is revolutionizing medicine. From vaccines to personalized cancer treatments, its precision and adaptability are reshaping how we prevent and treat disease. This technology is safe, rigorously tested and is fueled by decades of R&D. Here’s what else you need to know about how it works: phrma.org/blog/answering-com…
Scott LaGanga retweeted
💊 340𝐁 𝐂𝐨𝐯𝐞𝐫𝐞𝐝 𝐄𝐧𝐭𝐢𝐭𝐢𝐞𝐬 𝐒𝐭𝐢𝐥𝐥 𝐍𝐨𝐭 𝐏𝐚𝐬𝐬𝐢𝐧𝐠 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭𝐬 𝐭𝐨 𝐍𝐞𝐞𝐝𝐲 𝐏𝐚𝐭𝐢𝐞𝐧𝐭𝐬
Yikes! Only 3% to 5% of branded 340B prescriptions at retail and mail-order contract pharmacies were filled using a 340B drug discount card. That’s shockingly low—especially in a country where 32% of the population is uninsured or underinsured.
Per IQVIA, DSH hospitals have the biggest discrepancy between 340B prescriptions (74.7%) and card usage (42.8%). Perhaps not coincidentally, many of their contract pharmacies are located in higher-income areas.
Yet another massive disconnect between the program’s benefits and patient access. Transparency and accountability are long overdue.
Source: @IQVIA_global drugch.nl/4eUSpOx
#340B #DrugPricing #HealthEquity #Transparency #HealthPolicy #DrugChannels
Scott LaGanga retweeted
President Trump is right: Americans often overpay for medicine, and middlemen are cashing in, pocketing more in rebates and fees than the full prices of drugs in many other countries. Instead of implementing “foreign-first pricing,” here’s how I think we can lower drug prices for Americans in @statnews: statnews.com/2025/06/26/most…
Scott LaGanga retweeted
🚨Record year for #340B🚨
In 2024, 340B purchases hit $148B at WAC—nearly 3x the 2018 total. DCI estimates discounted purchases at $80B, leaving a $68B gross-to-net gap.
Massive scale. Zero transparency on how the $$ flows.
Source: @IQVIA_Institute drugch.nl/3FwhJgr
Scott LaGanga retweeted
AdventHealth — a tax-exempt, religious health system that runs 53 hospitals — generated a 17% operating margin and 23% net margin in Q1. Those profit margins were larger than Amazon, ExxonMobil, and Walt Disney. Many hospitals are doing just fine. statnews.com/2025/05/27/hosp…
